TAMIFLU
Hold Cadila Healthcare, target Rs 380: Emkay Global Financial Services
Hold Cadila Healthcare Ltd. at a price target of Rs 380.0 .
Lupin launches generic influenza treatment capsules in the US
The capsules, in the strengths of 30 mg, 45 mg and 75 mg, are generic versions of Hoffman-La Roche Inc's Tamiflu capsules in the same strengths, the company said.
Pharma stocks miss rally, but this stock defies trend, zooms 60% YTD!
The pharma company reported a five-fold jump in December quarter profit.
Natco Pharma launches Tamiflu generic capsules in US
The company's capsules are generic versions of Roche's Tamiflu drug
Natco Pharma surges 7% on drug approval
The stock rose 7.33 per cent to hit a high of Rs 650.90 on BSE. Volumes more than doubled on the counter to 98,000 shares, compared with a two-week average of 54,000 shares.
Natco Pharma gets ANDA nod for Tamiflu's generic version
Tamiflu is used to treat the flu (influenza) in people 2 weeks of age and older who have had flu symptoms for no more than 2 days.
- Go To Page 1

Natco settles patent suit with Gilead, others over Tamiflu
Natco Pharma and its partner Alvogen today said they have settled patent infringement suit with Gilead Sciences Inc and others over Tamiflu.

Natco Pharma shares surge over 9 per cent
The stock gained sharply by 9.09 per cent to settle at Rs 1,792.05 on the BSE. During the day, it jumped 10.48 per cent to Rs 1,815 -- its 52-week high.

Natco Pharma gets USFDA tentative nod for generic Tamiflu
The tentative approval of Oseltamivir Phosphate capsules by the US Food and Drug Administration is for multiple strengths of 30mg, 45 mg and 75 mg.

Swine flu virus now resistant to current medicine Tamiflu
Swine flu virus may be now resistant to key medicine Tamiflu, raising fears a new outbreak may be difficult to fight, warns Australian research.
Zanamivir sale curb worries docs
The government’s move to regulate the sale of Virenza (Zanamivir) in addition to Tamiflu (Oseltamivir) has doctors across India worried.
WHO says irrational Tamiflu use may make H1N1 virus resistant
Irrational use of swine flu drug can make the H1N1 virus resistant to the medicine making it fatal as the Tamiflu loses its efficiency, the World Health Organisation (WHO) has warned.
Hetero bags deal for 10 m Tamiflu
Hetero Drugs has pipped Ranbaxy Laboratories, Cipla, Natco Pharma, Strides Arcolabs and Roche India to bag half the government order to supply 20 million Tamiflu capsules.
West Bengal received fresh consignment of swine flu drug
West Bengal government has just received a fresh consignment of the swine flu drug, Tamiflu. The state has received one lakh tablets of the medicine from the Centre.
WB expands infrastructure for H1N1 patients
West Bengal government has just received a fresh consignment of the swine flu drug, Tamiflu. The state has received one lakh tablets of the medicine from the Centre.

Can't give Tamiflu to all suspected cases: Officials
At least 92 residents of Gurgaon have swine flu-like symptoms, but they have neither got their test reports nor been started on Tamiflu.
Pharma companies donate tamiflu
The Indian arm of Swiss pharma major Hoffmann-La Roche and Hyderabad-based Hetero Drugs have together donated one lakh dosages of Tamiflu medicine to government authorities.
‘Tamiflu can have bad side-effects on children’
Researchers at Oxford University have questioned the safety of the drug for children. They found in a study that it caused vomiting, dehydration and other complications in about 5% of cases among children aged between one and 12 years.
Makers of Tamiflu version see share prices surge
Share price of drug companies Ranbaxy, Natco and Strides Acrolabs, that make low-priced versions of anti-flu medicine Tamiflu, surged on Tuesday.
Strides Arcolab ready to supply Swine Flu drug
Drug firm Strides Acrolab on Tuesday said it is in a position to supply Oseltamivir Capsules, the only available medicine against Influenza A HINI virus (Swine Flu), to meet the demand both from domestic and overseas market.
Cipla, Ranbaxy in fray to bag govt contract for Tamiflu
Drugmakers Cipla, Ranbaxy, Hetero and Natco are expected to be in the fray to bag the government's contract to buy 20 million low cost anti-flu medicine Tamiflu.
Indian companies may pitch in with generic version of Tamiflu
“We have already received proposals from people on behalf of countries in Latin America, Mexico and Israel. We have the capability to supply 1.5 million dosages of the drug within 4-6 weeks,” said Cipla joint MD Amar Lulla.
GSK to up output of inhaler drug
With swine flu cases on the rise, governments across the world are covering their bases and stocking up on both the drugs available to treat swine flu, Tamiflu and Relenza.
Hetero bags mega chunk of govt's anti-flu drug deal
Hyderabad-based Hetero Drugs has bagged the lion’s share of the government’s 10-million anti-flu drug order.
Hetero Drugs close to receiving orders for its swine flu medicines
Hyderabad-based Hetero Drugs is close to receiving orders from foreign countries for its swine flu medicines worth at least $10 mn in the next few days, a top company executive said.
Ready to supply anti-flu drug at short notice, says Ranbaxy
Ranbaxy Laboratories has said it can supply generic version of anti-flu drug at a short notice.
Will swine flu be a boon for Indian generics?
Tamiflu is not patent-protected in India and some other emerging markets, but it is in the US, Europe, and Mexico. Top 10 Drugmakers by sale | Formula for successful biz
Local drug cos may chip in to treat swine flu
The swine flu outbreak, classified by the World Health Organisation as a “public health emergency of international concern”, may see Indian drug makers pitching in with the generic version of the antiviral Tamiflu as the world looks for quick, affordable options to counter the infection.
Load More